Related references
Note: Only part of the references are listed.Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER-Medicare Population Analysis
Ronald S. Go et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG 50120)
Rashid Khan et al.
HAEMATOLOGICA (2015)
Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy
B. Siontis et al.
BLOOD CANCER JOURNAL (2015)
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG 50120)
Rashid Khan et al.
HAEMATOLOGICA (2015)
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma
Elin Edda Sigurdardottir et al.
JAMA ONCOLOGY (2015)
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance An Operation Ranch Hand Veteran Cohort Study
Ola Landgren et al.
JAMA ONCOLOGY (2015)
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde et al.
JAMA ONCOLOGY (2015)
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)
Madhav V. Dhodapkar et al.
BLOOD (2014)
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
Niels W. C. J. van de Donk et al.
HAEMATOLOGICA (2014)
Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis
Brendan M. Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
B. A. Walker et al.
LEUKEMIA (2014)
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance
J. Hillengass et al.
LEUKEMIA (2014)
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
M. Merz et al.
LEUKEMIA (2014)
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma
E. Kastritis et al.
LEUKEMIA (2014)
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study
Robert A. Kyle et al.
LANCET HAEMATOLOGY (2014)
Idiopathic Bence-Jones proteinuria: a new characterization of an old entity
Michael Mian et al.
ANNALS OF HEMATOLOGY (2013)
How I treat monoclonal gammopathy of renal significance (MGRS)
Jean-Paul Fermand et al.
BLOOD (2013)
Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load
Kai Neben et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
G. Bianchi et al.
LEUKEMIA (2013)
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS
J. A. Katzmann et al.
LEUKEMIA (2013)
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma
J. T. Larsen et al.
LEUKEMIA (2013)
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
E. Kastritis et al.
LEUKEMIA (2013)
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
S. V. Rajkumar et al.
LEUKEMIA (2013)
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Maria-Victoria Mateos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
Lewin Eisele et al.
ANNALS OF HEMATOLOGY (2012)
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
Nelson Leung et al.
BLOOD (2012)
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status
L. Lopez-Corral et al.
LEUKEMIA (2012)
Diagnosis of Smoldering Multiple Myeloma
S. Vincent Rajkumar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
Giada Bianchi et al.
BLOOD (2010)
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
Ernesto Perez-Persona et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
Jens Hillengass et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
Angela Dispenzieri et al.
LANCET (2010)
Plasma Cell Labeling index in the Evaluation of Smoldering (Asymptomatic) Multiple Myeloma
Sumit Madan et al.
MAYO CLINIC PROCEEDINGS (2010)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Long-term follow-up of a population based cohort with monoclonal proteinaemia
Cees G. Schaar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Proposal and Validation of Prognostic Scoring Systems for IgG and IgA Monoclonal Gammopathies of Undetermined Significance
Francesca Rossi et al.
CLINICAL CANCER RESEARCH (2009)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Ernesto Perez-Persona et al.
BLOOD (2007)
Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance
Davide Rossi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Monoclonal gammopathy of undetermined significance:: Predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size
Laura Rosinol et al.
MAYO CLINIC PROCEEDINGS (2007)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance
S Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BLOOD (2005)
Prognostic factors and predictors of outcome of immunoglobulin m monoclonal gammopathy of undetermined significance
RA Kyle et al.
CLINICAL LYMPHOMA (2005)
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance
RA Kyle et al.
BLOOD (2003)
Smoldering multiple myeloma: natural history and recognition of an evolving type
L Rosinol et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance
A Taher et al.
LUPUS (2003)
Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
C Cesana et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Malignant transformation of monoclonal gammopathy of undetermined significance: Cumulative incidence and prognostic factors
N Van De Donk et al.
LEUKEMIA & LYMPHOMA (2001)
Share Paper
